Regenerative medicine company, Carmell Therapeutics, announced the execution of a definitive agreement and plan of merger (the “Merger Agreement”) with Flagstaff-based Axolotl Biologix. Axolotl develops, designs, and sells products that are human amnion-based, for...

    Quince Therapeutics (Nasdaq: QNCX) in its agreement to acquire EryDel SpA in a stock-for-stock upfront exchange and potential downstream milestone cash payments. Quince Therapeutics is a biotechnology company focused on acquiring, developing, and commercializing...

Advanco, established as a global pharmaceutical and life sciences track and trace solutions provider, has announced the acquisition of manufacturing automation specialist Vantage Consulting Group. The company will continue to be called advanco, with an enlarged client portfolio of...

TraceLink, a leading digital network platform company enabling end-to-end product orchestration, has announced a partnership with PharmaLink. TraceLink will provide comprehensive DSCSA capabilities for PharmaLink customers, enabling pharmacy dispensers to meet the regulatory...

  Talaris Therapeutics, Inc and Tourmaline Bio, Inc. , a late-stage clinical biotechnology company developing transformative medicines, announced that the companies have entered into a definitive agreement under which Tourmaline will combine with Talaris in an all-stock...

Eli Lilly and Co. said Thursday it has agreed to buy a small biotech based in Massachusetts Sigilon Therapeutics Inc in a deal worth about $309 million. Since 2018, Lilly and Sigilon have worked together to develop encapsulated cell therapies, including SIG-002, for the treatment of...

  Spanish packaging firm Inden Pharma is planning to expand its business to India after partnering with Austria-based ALPLApharma that specialises in plastic packaging for pharmaceuticals. In a bid to increase their presence in the global market for pharmaceutical packaging, the...

      EyePoint Pharmaceuticals (NASDAQ:EYPT) entered into a definitive agreement for the sale of YUTIQ (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences. YUTIQ is a treatment for chronic non-infectious uveitis affecting the posterior segment of...

  Juno Pharmaceuticals Canada (“Juno”), a leader in the commercialization of specialty pharmaceuticals, announced the acquisition of Omega Laboratories (“Omega”), one of Canada’s largest domestic specialty injectable pharmaceutical manufacturers. The new combined company is now...

  GSK plc (LSE/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) today announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical company working to better the lives of patients suffering from...